Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.
about
Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complexTuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth.A panel of four genes accurately differentiates benign from malignant thyroid nodules.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis.Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.
P2860
Q28070171-E0A536E9-16A3-4D35-9895-36D454600B22Q30248734-5B3A94E7-90A4-442D-ABE8-60C949960F5EQ37374678-EC2658B1-7133-4273-82F6-95FF0E6FB555Q38807302-348BE9F8-C516-4B54-A6CF-CF182C4FA178Q47662133-51544B9F-2FD9-4D79-86AA-36AD03DEE9D9Q49477361-CB2E2121-D583-4F0E-9089-8218F8B12844Q54996973-05244BDB-96C8-48AD-8BC6-4AA498BBA286
P2860
Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mesenchymal Tumorigenesis Driv ...... nt of mTOR Pathway Activation.
@en
type
label
Mesenchymal Tumorigenesis Driv ...... nt of mTOR Pathway Activation.
@en
prefLabel
Mesenchymal Tumorigenesis Driv ...... nt of mTOR Pathway Activation.
@en
P2093
P2860
P1433
P1476
Mesenchymal Tumorigenesis Driv ...... ent of mTOR Pathway Activation
@en
P2093
Devipriya Sankarasharma
Jeanine D'Armiento
Kiran Chada
Patrick Geraghty
Sarah Marks
P2860
P304
P356
10.1158/0008-5472.CAN-15-1287
P407
P577
2016-02-02T00:00:00Z